HK Stock MarketDetailed Quotes

01513 LIVZON PHARMA

Watchlist
  • 25.350
  • -0.550-2.12%
Market Closed Apr 19 16:08 CST
23.49BMarket Cap10.89P/E (TTM)

LIVZON PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Cash flow from operating activities
Profit adjustment
Impairment and provisions:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Revaluation surplus:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Asset sale loss (gain):
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Depreciation and amortization:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Operating profit before the change of operating capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Change of operating capital
Cash  from business operations
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net cash from operations
17.18%3.25B
19.72%2.21B
-13.96%1.23B
-57.80%299.78M
45.75%2.77B
41.57%1.85B
111.34%1.43B
38.03%710.31M
-11.96%1.9B
-14.00%1.31B
Cash flow from investment activities
Sale of fixed assets
388.87%14.46M
852.19%7.38M
-90.87%53K
----
-67.44%2.96M
-89.45%775.17K
-38.17%580.55K
395.73%177.97K
77.68%9.09M
486.60%7.35M
Purchase of fixed assets
12.73%-820.45M
29.83%-554.64M
32.65%-399.06M
27.24%-146.42M
28.18%-940.15M
1.99%-790.43M
-22.37%-592.48M
17.95%-201.22M
-102.34%-1.31B
-96.73%-806.46M
Sale of subsidiaries
----
----
----
----
----
----
----
----
-37.98%3.31M
-37.98%3.31M
Acquisition of subsidiaries
---22.46M
---22.46M
---22.46M
---12.46M
----
----
----
----
----
----
Recovery of cash from investments
--471.56M
--374.33M
--374.33M
--70.03M
----
----
----
----
-51.61%110.3M
-16.76%110.3M
Cash on investment
-18.53%-473.16M
-1,243.62%-407.64M
-1,243.82%-407.69M
79.62%-6.18M
49.21%-399.18M
96.08%-30.34M
95.92%-30.34M
-51.69%-30.34M
-508.42%-786M
-938.73%-774M
Other items in the investment business
14.24%121.67M
-3.62%49.1M
-70.24%17.73M
134.58%30.21M
11.52%106.5M
-40.86%50.94M
-4.54%59.58M
-23.16%12.88M
36.57%95.5M
103.52%86.14M
Net cash from investment operations
42.40%-708.37M
27.97%-553.93M
22.31%-437.1M
70.33%-64.83M
34.47%-1.23B
44.00%-769.05M
46.48%-562.65M
-12.80%-218.51M
-301.18%-1.88B
-353.23%-1.37B
Net cash before financing
64.67%2.54B
53.72%1.66B
-8.51%790.21M
-52.22%234.96M
5,967.38%1.54B
1,686.37%1.08B
329.53%863.73M
53.26%491.8M
-98.50%25.43M
-105.60%-68.01M
Cash flow from financing activities
New borrowing
-1.51%3.66B
-19.57%2.73B
-26.34%1.86B
-38.35%1.03B
32.63%3.71B
47.33%3.4B
108.09%2.52B
154.01%1.68B
17.47%2.8B
32.19%2.3B
Refund
-11.44%-3.13B
10.17%-2.33B
37.31%-1.21B
55.11%-595.57M
-37.92%-2.8B
-50.58%-2.59B
-167.62%-1.93B
-139.95%-1.33B
-11.14%-2.03B
-5.70%-1.72B
Dividends paid - financing
-19.14%-1.9B
-17.70%-1.84B
35.54%-937.86M
-84.88%-31.17M
-5.98%-1.59B
-8.07%-1.57B
-6.01%-1.45B
-16.32%-16.86M
-27.04%-1.5B
-23.66%-1.45B
Absorb investment income
81.15%76.53M
47.62%39.24M
63.92%36.79M
73.64%36.79M
-94.71%42.25M
-96.47%26.58M
-96.79%22.44M
-96.55%21.19M
123.44%798.27M
162.21%753.71M
Other items of the financing business
-360.70%-369.72M
-1,809.63%-364.44M
-1,215.62%-153.1M
-22,260.25%-126.89M
90.86%-80.25M
97.57%-19.08M
98.52%-11.64M
99.93%-567.48K
-255.15%-878.24M
-229.94%-784.79M
Net cash from financing operations
-130.01%-1.66B
-133.41%-1.77B
52.20%-409.89M
-10.37%316.69M
11.61%-720.36M
15.70%-757.59M
11.63%-857.43M
528.36%353.34M
-57.33%-815.02M
10.92%-898.66M
Effect of rate
-83.95%20.04M
-74.95%33.03M
-50.12%31.98M
-147.55%-23.82M
436.17%124.89M
812.83%131.85M
390.63%64.1M
-804.20%-9.62M
51.76%-37.15M
39.56%-18.5M
Net Cash
-4.60%903.72M
-116.95%-76.79M
485.62%412.29M
-36.83%527.83M
214.59%947.33M
146.00%453.13M
105.14%70.4M
252.02%835.52M
-175.30%-826.74M
-661.61%-985.16M
Begining period cash
10.38%10.07B
10.38%10.07B
10.38%10.07B
10.38%10.07B
-8.31%9.13B
-8.31%9.13B
-8.31%9.13B
-8.31%9.13B
12.40%9.95B
12.40%9.95B
Cash at the end
8.97%10.98B
4.36%10B
14.02%10.48B
6.42%10.6B
10.38%10.07B
6.82%9.58B
7.13%9.2B
-2.24%9.96B
-8.31%9.13B
-0.69%8.97B
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Cash flow from operating activities
Profit adjustment
Impairment and provisions: --0--0--0--0--0--0--0--0--0--0
Revaluation surplus: --0--0--0--0--0--0--0--0--0--0
Asset sale loss (gain): --0--0--0--0--0--0--0--0--0--0
Depreciation and amortization: --0--0--0--0--0--0--0--0--0--0
Operating profit before the change of operating capital --0--0--0--0--0--0--0--0--0--0
Change of operating capital
Cash  from business operations --0--0--0--0--0--0--0--0--0--0
Net cash from operations 17.18%3.25B19.72%2.21B-13.96%1.23B-57.80%299.78M45.75%2.77B41.57%1.85B111.34%1.43B38.03%710.31M-11.96%1.9B-14.00%1.31B
Cash flow from investment activities
Sale of fixed assets 388.87%14.46M852.19%7.38M-90.87%53K-----67.44%2.96M-89.45%775.17K-38.17%580.55K395.73%177.97K77.68%9.09M486.60%7.35M
Purchase of fixed assets 12.73%-820.45M29.83%-554.64M32.65%-399.06M27.24%-146.42M28.18%-940.15M1.99%-790.43M-22.37%-592.48M17.95%-201.22M-102.34%-1.31B-96.73%-806.46M
Sale of subsidiaries ---------------------------------37.98%3.31M-37.98%3.31M
Acquisition of subsidiaries ---22.46M---22.46M---22.46M---12.46M------------------------
Recovery of cash from investments --471.56M--374.33M--374.33M--70.03M-----------------51.61%110.3M-16.76%110.3M
Cash on investment -18.53%-473.16M-1,243.62%-407.64M-1,243.82%-407.69M79.62%-6.18M49.21%-399.18M96.08%-30.34M95.92%-30.34M-51.69%-30.34M-508.42%-786M-938.73%-774M
Other items in the investment business 14.24%121.67M-3.62%49.1M-70.24%17.73M134.58%30.21M11.52%106.5M-40.86%50.94M-4.54%59.58M-23.16%12.88M36.57%95.5M103.52%86.14M
Net cash from investment operations 42.40%-708.37M27.97%-553.93M22.31%-437.1M70.33%-64.83M34.47%-1.23B44.00%-769.05M46.48%-562.65M-12.80%-218.51M-301.18%-1.88B-353.23%-1.37B
Net cash before financing 64.67%2.54B53.72%1.66B-8.51%790.21M-52.22%234.96M5,967.38%1.54B1,686.37%1.08B329.53%863.73M53.26%491.8M-98.50%25.43M-105.60%-68.01M
Cash flow from financing activities
New borrowing -1.51%3.66B-19.57%2.73B-26.34%1.86B-38.35%1.03B32.63%3.71B47.33%3.4B108.09%2.52B154.01%1.68B17.47%2.8B32.19%2.3B
Refund -11.44%-3.13B10.17%-2.33B37.31%-1.21B55.11%-595.57M-37.92%-2.8B-50.58%-2.59B-167.62%-1.93B-139.95%-1.33B-11.14%-2.03B-5.70%-1.72B
Dividends paid - financing -19.14%-1.9B-17.70%-1.84B35.54%-937.86M-84.88%-31.17M-5.98%-1.59B-8.07%-1.57B-6.01%-1.45B-16.32%-16.86M-27.04%-1.5B-23.66%-1.45B
Absorb investment income 81.15%76.53M47.62%39.24M63.92%36.79M73.64%36.79M-94.71%42.25M-96.47%26.58M-96.79%22.44M-96.55%21.19M123.44%798.27M162.21%753.71M
Other items of the financing business -360.70%-369.72M-1,809.63%-364.44M-1,215.62%-153.1M-22,260.25%-126.89M90.86%-80.25M97.57%-19.08M98.52%-11.64M99.93%-567.48K-255.15%-878.24M-229.94%-784.79M
Net cash from financing operations -130.01%-1.66B-133.41%-1.77B52.20%-409.89M-10.37%316.69M11.61%-720.36M15.70%-757.59M11.63%-857.43M528.36%353.34M-57.33%-815.02M10.92%-898.66M
Effect of rate -83.95%20.04M-74.95%33.03M-50.12%31.98M-147.55%-23.82M436.17%124.89M812.83%131.85M390.63%64.1M-804.20%-9.62M51.76%-37.15M39.56%-18.5M
Net Cash -4.60%903.72M-116.95%-76.79M485.62%412.29M-36.83%527.83M214.59%947.33M146.00%453.13M105.14%70.4M252.02%835.52M-175.30%-826.74M-661.61%-985.16M
Begining period cash 10.38%10.07B10.38%10.07B10.38%10.07B10.38%10.07B-8.31%9.13B-8.31%9.13B-8.31%9.13B-8.31%9.13B12.40%9.95B12.40%9.95B
Cash at the end 8.97%10.98B4.36%10B14.02%10.48B6.42%10.6B10.38%10.07B6.82%9.58B7.13%9.2B-2.24%9.96B-8.31%9.13B-0.69%8.97B
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg